Summary
1. The effects of intravenous infusion with the alpha2 adrenoceptor selective agonist alpha methylnoradrenaline on pressor responses to alpha adrenoceptor agonists, alpha2 adrenoceptor mediated platelet aggregation and adenylate cyclase were examined in conscious rabbits. 2. Pressor responses to alpha methylnoradrenaline but not phenylephrine were decreased in a dose dependent manner during methylnoradrenaline infusion at all times examined. 3. Recovery of these responses after stopping infusion was dependent on both the dose infused and the duration of the infusion. 4. Alpha methylnoradrenaline infusion resulted in a dose and time dependent decrease in the pro-aggregatory response of platelet to adrenaline without any significant change in the response to ADP or in the number of [3H] yohimbine binding sites. 5. The ability of PGE1 to stimulate adenylate cyclase was not influenced by alpha methylnoradrenaline infusions. However, reversal of this stimulation by adrenaline was decreased by relatively long (30 min) infusions of the highest dose of alpha methylnoradrenaline examined. 6. It is concluded that alpha methylnoradrenaline infusions resulted in desensitisation of all the alpha2 adrenoceptor mediated responses examined. However the time course for the desensitisation apparently differed according to the response examined.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Born GVR (1962) Quantitative investigations into the aggregation of blood platelets. J Physiol (Lond) 162:67
Bylund DB, U'Prichard DC (1983) Characterisation of alpha, and alpha2 adrenergic receptors. Int Rev Neurobiol 24:343–431
Clare KA, Scrutton MC, Thompson NT (1984) Effects of alpha2 adrenoceptor agonists and of related compounds on aggregation of and on adenylate cyclase activity in human platelets. Br J Pharmac 82:467–476
Daiguji M, Meltzer HY, U'Prichard DC (1981) Human platelet alpha2 adrenergic receptors: labelling with 3H yohimbine, a selective antagonist ligand. Life Sci 28:2705–2717
Deighton NM, Hamilton CA, Jones CR (1985) Acute agonist regulation of alpha2 adrenoceptors in vitro in the rabbit. Br J Pharmacol 86:741P
Gilman AG (1970) A protein binding assay for adenosine 3′,5′cyclic monophosphate. Proc Nat Acad Sci USA 67:305–312
Hannah JAM, Hamilton CA, Reid JL (1984) An analysis of the pressor responses to putative alpha, and alpha2 adrenoceptor agonists given intravenously to conscious rabbits. J Anton Pharm 4:73–76
Harden TK (1983) Agonist-induced desensitisation of the beta adrenergic receptor-linked adenylate cyclase. Pharmacol Reviews 35:5–32
Haslam RJ (1975) Roles of cyclic nucleotides in platelet function. In: Biochemistry and pharmacology of platelets. Aba Foundation Symposium 35. Elsevier, Amsterdam, pp 121–143
Hayes JS, Pollock GD, Fuller RW (1984) In vivo cardiovascular responses to isoproterenol dopamine and tyramine after prolonged infusion of isoproterenol. J Pharmacol Exp Ther 231:633–639
Jenner DA, Brown MJ, Lhoste FJM (1981) Determination of alpha methyldopa, alpha methylnoradrenaline, noradrenaline and adrenaline in plasma using high performance liquid chromatography with electrochemical detection. J Chromatogr 224:507–512
Karliner JS, Motulsky HJ, Insel PA (1982) Apparent ‘down regulation’ of human platelet alpha2 adrenergic receptors is due to retained agonist. Mol Pharmacol 21:36–43
Kerry R, Scrutton MC (1983) Platelet beta adrenoceptors. Br J Pharmac 79:681–691
Lefkowitz RJ, Stadel JM, Caron MG (1983) Adenylate cyclasecoupled beta adrenergic receptors: structures and mechanisms of activation and desensitisation. Ann Rev Biochem 52:159–186
Mickey JV, Tate R, Mulliken D, Lefkowitz RJ (1975) Regulation of adenylate cyclase-coupled beta adrenergic receptor binding sites by beta adrenergic catecholamines in vitro. Mol Pharmacol 12:409–419
Snavely MD, Ziegler MG, Insel PA (1985) A new approach to determine rates of receptor appearance and disappearance in vivo: application to agonist mediated down-regulation of rat renal cortical beta, and beta2 adrenergic receptors. Mol Pharmacol 27:19–26
Staehelin M, Simons P, Jaeggi K, Wigger N (1983) CGP-12177: a hydrophilic beta adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells. J Biol Chem 258:3496–3502
Strader CD, Sibley DR, Lefkowitz RJ (1984) Association of sequestered beta adrenergic receptors with the plasma membrane: a novel mechanism for receptor down regulation. Life Sci 635:1601–1610
Strasser RH, Cerione RA, Codina J, Caron MG, Lefkowitz RJ (1985) Homologous desensitisation of the beta adrenergic receptor: functional integrity of the desensitised receptor: functional integrity of the desensitised receptor from mammalian lung. Mol Pharmacol 28:237–245
Swart SS, MacGuire M, Wood JK and Barnett DB (1985) Alpha2 adrenoceptor coupling to adenylate cyclase in adrenaline insensitive human platelets. Eur J Pharmacol 116:113–119
Toews ML, Perkins JP (1984) Agonist-induced changes in beta adrenergic receptors on intact cells. J Biol Chem 259:2227–2235
Tsai BS, Lefkowitz RJ (1979) Agonist-specific effects of guanine nucleotides on alpha adrenergic receptors in human platelets. Mol Pharmacol 16:61–66
Author information
Authors and Affiliations
Additional information
Send offprint requests to C. A. Hamilton at the above address
Rights and permissions
About this article
Cite this article
Hamilton, C.A., Deighton, N.M. & Reid, J.L. Rapid and reversible desensitisation of vascular and platelet alpha2 adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 335, 534–540 (1987). https://doi.org/10.1007/BF00169120
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00169120